Dignity Finance PLC
Notes to the financial statements
for the period ended 30 December 2022 (continued)
1 Principal accounting policies (continued)
Going concern (continued)
consideration to controllable mitigations, for example reducing discretionary capital expenditure and marketing
spend, there were no plausible scenarios in which the Dignity Group would not have sufficient liquidity in the
going concern period.
Based on a review of its cost base as part of the forecasting, the Dignity Group has identified cost saving
opportunities that could provide additional liquidity and EBITDA headroom if needed. These central overhead
savings are within the Dignity Group’s control but are not planned, nor anticipated to be required.
Some controllable mitigating factors do not have an immediate impact so there is still a risk of breaching the DSCR
covenant at 31 December 2023 and 31 March 2024, which has resulted in a material uncertainty (see Conclusion
below).
Impact should there be a breach of the DSCR covenant
However, any breach of the covenant does not give rise to an immediate requirement to repay the associated Loan
Notes. Rather, such a breach results in a requirement for the noteholder trustees to appoint a financial adviser who
will review the financial and operational circumstances of the Securitised Group prior to making recommendations
as to how the breach can be resolved considering whether the Securitised Group is likely to be able to remedy such
a breach. If the financial adviser considers that the Securitised Group is likely to be able to remedy such a breach
this will be done by the placing of cash collateral in an amount which, if it had been placed for the relevant period
in respect of which the covenant was breached, would have generated interest sufficient (if added to EBITDA for
the relevant period) to have ensured that the covenant was not breached. The interest rate on which the cash
collateral would accrue interest to add to the EBITDA calculation would be measured at the rate that is earned on
such cash collateral as at the date it was placed (e.g., a deposit rate quoted by a bank). If the Dignity Group is
unable to remedy such a breach the Loan Notes would be repayable on an accelerated basis and could be repayable
immediately at the request of the noteholders.
Period beyond the going concern period
The Dignity Group has also considered the period beyond 30 April 2024 to assess if there are any significant risks
that exist that would otherwise impact the going concern assumption. As the current equity cure does not benefit
the DSCR covenant reporting after 31 December 2023 as the last 12 months cash contributions will have expired,
the base forecast covenant headroom is reduced at that point.
To pr
ovide further headroom and reduce the risk of a covenant breach, the Dignity Group has continued to work on
a long-term solution to improve the Group’s capital structure. On 7 September 2022 a consent solicitation with c.61
per cent support from its Class A noteholders was launched. The voting concluded on 29 September 2022 and the
consents were approved, with 94.42 per cent of votes cast in favour. As a result of this, consents from noteholders
have been gained to permit a potential transaction involving the realisation of value from selected crematoria assets
(the trading performance for which is included within the Securitisation Group), with the proceeds of such a
transaction being applied in a partial redemption of the Class A Notes. These consents apply for a 12 month period
to 29 September 2023.
Dignity plc will be required to inject a minimum of £70 million into the Securitisation Group to partially repay
some of the Class A Notes outstanding in consideration for trade and assets leaving the Securitisation Group. If the
transaction completes by 30 June 2023 and £70 million is the net realisation, then upon repayment of debt at this
level, this will result in a deleveraging of the Dignity Group and a positive impact of £6.1 million on the DSCR
covenant calculations, i.e., a reduction of the DSCR from c.£51 million to c.£44.9 million for 31 March 2024. If the
transaction takes longer to complete and is completed between 30 June 2023 and 30 September 2023 there would
be no positive impact in March 2024 as the first possible date for repayment will be 29 December 2023. It would
have a full year impact of £10.2 million on the DSCR covenant calculations, i.e., a reduction of the DSCR from
c.£51 million to c.£41 million in 2024.
In addition, upon completion of the proposed transaction within the timeframe permitted by the noteholder consent,
there are amendments to the documents that will allow further equity cures, with restrictions, to be made going
forward should they be required. If the transaction completes before 30 June 2023, this can be used to supplement
any EBITDA shortfall at 31 December 2023 and 31 March 2024.